Cannabis Report
Home > Boards > US Listed > Biotechs >

Viking Therapeutics, Inc. (VKTX)

VKTX RSS Feed
Add VKTX Price Alert      Hide Sticky   Hide Intro
Moderator: DMOST, greens12
Search This Board: 
Last Post: 6/21/2018 10:49:40 PM - Followers: 56 - Board type: Free - Posts Today: 0

 
Novel therapeutics for metabolic<Br/>and endocrine disorders
  1. 2
    2
    2
     
 

VK0612

Viking Therapeutics is focused on the development of novel therapeutics for patients suffering from metabolic and endocrine disorders.

Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. Viking’s research and development activities leverage the Company’s expertise in metabolism to develop innovative therapeutics that improve patients’ lives. The Company’s lead clinical program is VK5211, an orally available, non-steroidal selective androgen receptor modulator, or SARM, for the treatment of patients recovering from non-elective hip fracture surgery. The Company’s second program is focused on the development of first-in-class, selective, small molecule agonists of the thyroid receptor beta, or TRß, for adrenoleukodystrophy, or ALD, and lipid disorders such as hypercholesterolemia and non-alcoholic steatohepatitis, or NASH. Viking is also developing additional programs targeted at diabetes, metabolic diseases and anemia.
 

Overview

Pills

We have a portfolio of five drug candidates in clinical trials or preclinical studies

Our lead clinical program, VK5211, is a novel, orally available, non-steroidal selective androgen receptor modulator, or SARM, in development for the treatment of patients recovering from non-elective hip fracture surgery. VK5211 is designed to produce the therapeutic benefits of testosterone in muscle and bone with improved safety, tolerability and patient acceptance. We have initiated a Phase 2 clinical trial with VK5211 in patients recovering from non-elective hip fracture surgery. For more information on this study please visit NCT02578095.

Our second pipeline program is focused on the development of novel small molecule agonists of the thyroid beta (TRb) receptor, VK2809 and VK0214. These novel TRb agonists are being developed for hypercholesterolemia and fatty liver disease and X-linked adrenoleukodystrophy, or X-ALD. We have initiated Phase 2 clinical development of VK 2809 in hypercholesterolemia and fatty liver disease. VK0214 is in preclinical development for X-ALD.

We are also developing VK0612, a first-in-class, orally available drug 

Cannabis Report
VKTX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VKTX News: Current Report Filing (8-k) 06/12/2018 07:13:55 AM
VKTX News: Viking Therapeutics Announces Closing of Public Offering of Common Stock 06/12/2018 07:05:00 AM
VKTX News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 06/07/2018 05:15:48 PM
VKTX News: Current Report Filing (8-k) 06/07/2018 01:42:39 PM
VKTX News: Registration of Additional Securities (up to 20%) (s-3mef) 06/07/2018 09:05:39 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#1453   Viking Therapeutics, Inc. (VKTX) dropped a DMOST 06/21/18 10:49:40 PM
#1452   Any reason for the drop today? (besides the djmurdock 06/21/18 03:40:07 PM
#1451   Thanks waffles good luck with the move! Lynx7 06/21/18 03:08:40 PM
#1450   pffff peterus 06/21/18 11:32:05 AM
#1449   Greetings... haven’t been on here much. All ZeWaffleBaron 06/20/18 11:54:57 PM
#1448   Viking Therapeutics, Inc. ( VKTX ).....Just some rec DMOST 06/20/18 08:41:13 AM
#1446   should see some news next month ...holding this peterus 06/20/18 08:23:24 AM
#1445   shortie playing peterus 06/20/18 08:12:00 AM
#1444   Can I ask what this is showing us? Sncgolf03 06/20/18 08:06:39 AM
#1443   investorshub.advfn.com/uimage/uploads/2018/6/20/qualvVKTX.PNG DMOST 06/20/18 06:52:05 AM
#1442   VKTX ready to move up to 15.00 greens12 06/16/18 01:54:13 PM
#1441   Cash for NASH: 2 Top Biotech Takeover Targets DMOST 06/15/18 03:14:17 PM
#1440   agreed, we are just getting started here. Congrats greens12 06/15/18 01:06:04 PM
#1439   VKTX , I like this posters opinion ( DMOST 06/15/18 07:08:18 AM
#1438   In fact, if i was a fund guy tootalljones 06/14/18 09:45:15 PM
#1437   I take quiet confidence in this comment by Madrigal: tootalljones 06/14/18 09:40:46 PM
#1436   Thank you bigJake...so Madigal has less than 3X tootalljones 06/14/18 09:17:20 PM
#1435   Here's Why Viking Therapeutics Rose as Much as DMOST 06/14/18 03:47:39 AM
#1434   Yeah man, 160 million dollars in the bank, greens12 06/14/18 12:40:42 AM
#1433   Really ? is that why Institutional ownership has greens12 06/14/18 12:36:37 AM
#1432   They got the cash...no more propping. Only retail Trader1151 06/13/18 11:24:09 PM
#1431   I think Madrigal just raised $300M @ $305 bigjake 06/13/18 05:49:50 PM
#1430   Like I said...it should be 75.00 if correctly greens12 06/13/18 03:03:17 PM
#1429   i expect Viking to make a consistent bee tootalljones 06/13/18 02:20:24 PM
#1428   at a market cap of just 1B,(100% upwards tootalljones 06/13/18 02:16:50 PM
#1427   Agreed.back the of napkin shows at merely 1/10tH tootalljones 06/13/18 01:59:21 PM
#1426   VKTX should be trading at 75.00 right now greens12 06/13/18 01:52:10 PM
#1425   VKTX has around 160 million in cash. tootalljones 06/13/18 01:48:02 PM
#1424   post that question to ZeWafflebaron on this board greens12 06/13/18 01:47:52 PM
#1423   Anyone have any input on how concerning the Sncgolf03 06/13/18 12:52:14 PM
#1422   11.00 right now, the shorts are just greens12 06/13/18 12:31:05 PM
#1421   VKTX: Final Patient Enrolled in P2 Trial of DMOST 06/13/18 07:31:36 AM
#1420   Odds Bodkins.............or, "Odsbodlikins... you have a strange sort DMOST 06/12/18 11:28:53 AM
#1419   sick puppy peterus 06/12/18 11:19:20 AM
#1418   Viking Therapeutics, Inc. (VKTX) .....And with that DMOST 06/12/18 10:37:53 AM
#1417   Yes sir, I raised my target from greens12 06/11/18 08:08:53 PM
#1416   Good Job. hold for Q4 , should triple greens12 06/11/18 08:06:44 PM
#1415   30 EOY Willie2002 06/11/18 07:05:47 PM
#1414   In 2200 shares at 10.65. Looks really strong xio8up 06/11/18 04:10:50 PM
#1413   fun it is... could see a nice run peterus 06/11/18 03:20:24 PM
#1412   Shorts are getting Squeezed...this is fun. greens12 06/11/18 03:09:51 PM
#1411   The difference in market cap between MDGL and staccani 06/10/18 01:16:59 PM
#1410   It's a coin flip...... particularly now that it bigjake 06/10/18 12:07:15 PM
#1409   Good positive article...... Viking Therapeutics, Inc. (VKTX[/c DMOST 06/10/18 04:52:32 AM
#1408   Revisiting Viking Therapeutics https://seekingalpha.com/instablog/498952-bret-je greens12 06/09/18 12:27:42 PM
#1407   little vktx , still trading within its range.... GO FIGURE[/color DMOST 06/07/18 05:13:14 PM
#1406   The more you post the higher this stock greens12 06/07/18 02:56:30 PM
#1405   little vktx .........And so it should it the market DMOST 06/07/18 01:37:59 PM
#1404   Madrigal stock will tank when VKTX Vk2809 results greens12 06/07/18 01:30:29 PM
#1403   Little vktx , and with that I will be disengaging........[ DMOST 06/07/18 01:26:42 PM
PostSubject